Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 4.1 Specimen Class a Common Stock Certificate
- 5.1 Opinion of White & Case LLP As to the Validity of the Securities Being Registered
- 10.34 Exclusive License Agreement by and Between Eqrx, Inc. and G1 Therapeutics, Inc. Dated June 22, 2020
- 10.35 License Agreement by and Between Eqrx, Inc. and Cstone Pharmaceuticals Dated October 26, 2020
- 23.2 Consent of Ernst & Young LLP
- 99.1 Form of Preliminary Proxy Card
- 99.11 Consent of Houlihan Loukey Capital, Inc
- Download Excel data file
- View Excel data file
Associated filings
- 2 Dec 21 EFFECT Notice of effectiveness
- 1 Dec 21 424B3 Prospectus supplement
- 30 Nov 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 23 Nov 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
29 Oct 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 1 Oct 21 S-4/A Registration of securities issued in business combination transactions (amended)
- 25 Aug 21 S-4 Registration of securities issued in business combination transactions
EQRX similar filings
Filing view
External links
